Novo Nordisk A/S (NVO) stock has gained 37.06% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NVO stock a score of 66 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 73. NVO's rank also includes a long-term technical score of 71. The fundamental score for NVO is 52. In addition to the average rating from Wall Street analysts, NVO stock has a mean target price of $116.55. This means analysts expect the stock to increase 16.20% over the next 12 months.
NVO has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on NVO!
Novo Nordisk A/S (NVO) stock has gained 2.72% while the S&P 500 is lower by -0.16% as of 10:08 AM on Wednesday, Oct 13. NVO has gained $2.68 from the previous closing price of $97.65 on volume of 135,805 shares. Over the past year the S&P 500 has gained 23.69% while NVO has gained 37.06%. NVO earned $2.97 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 33.77.
Click Here to get the full Stock Report for Novo Nordisk A/S stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
